Consecutive Macular Edema and Visual Outcome in Branch Retinal Vein Occlusion

Table 4

Evaluation of prognostic factors between the 2 groups.

Characteristics	Gainer; (45 patients)	Nongainer; (35 patients)	𝑃 value
Age (years)*	58.15±9.69	60.71±12.07	0.324
Duration of symptom (days)*	34.53±71.06	28.31±45.69	0.471
Baseline visual acuity*; (logMAR)	0.30±0.20; (0.66±0.37)	0.45±0.33; (0.54±0.50)	0.060
Baseline CMT (𝜇m)*	554.79±152.52	520.75±196.78	0.414
Macular ischemia
Yes	5 (11.1%)	8 (22.8%)
No	32 (71.1%)	17 (48.5%)
Undetermined	8 (17.7%)	10 (28.5%)
Mean follow-up (months)*	19.76±8.49	19.03±7.71	0.705
Total duration of ME (months)*	5.23±2.29	6.87±4.04	0.031
Consecutive duration of ME (months)*	3.33±1.50	5.24±2.39	0.000

∗Mean ± SD; CMT: central macular thickness; ME: macular edema.